Status:
COMPLETED
Kidney Donor Outcomes Cohort (KDOC) Study
Lead Sponsor:
Beth Israel Deaconess Medical Center
Collaborating Sponsors:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Conditions:
Living Donor Nephrectomy
Eligibility:
All Genders
18+ years
Brief Summary
Live donor kidney transplantation (LDKT) is important because its outcomes for recipients are superior to those of deceased donor transplantation, and it yields significant cost savings to the healthc...
Detailed Description
Kidney transplantation extends and improves the lives of adults with end-stage renal disease (ESRD). Live donor kidney transplantation (LDKT) has many advantages over deceased donor transplantation fo...
Eligibility Criteria
Inclusion
- at least 18 years old
- residential or cell phone service
- written informed consent
- medically cleared for donor nephrectomy (donor)
- medically cleared for transplant surgery (recipient)
- did not progress to donation, although medically eligible (control)
- completed preliminary labs (control)
Exclusion
- inability or unwillingness to provide informed consent
- inability to speak and read English or Spanish
Key Trial Info
Start Date :
August 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 1 2018
Estimated Enrollment :
720 Patients enrolled
Trial Details
Trial ID
NCT01427452
Start Date
August 1 2011
End Date
February 1 2018
Last Update
March 20 2018
Active Locations (7)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Arizona
Tucson, Arizona, United States
2
University of Iowa
Iowa City, Iowa, United States
3
Maine Medical Center
Portland, Maine, United States
4
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States